邻氰基氯苄

2022-09-01

对氯邻硝基苯胺（红色基3GL）
p-Chloro-o-nitroaniline (Red base 3GL)

2016-10-22

p-톨루엔술폰클로르아마이드 소듐 3수화물 (시약)
对甲苯磺基氯胺钠三水合物

2018-12-24

5-氨基-3-氰基-1-(2,6-二氯-4-三氟甲基苯基)吡唑

2023-04-14

Journal AWWA - The Effect of Sulfur-Based Reducing Agents and GAC Filtration on Chlorine Dioxide By-Products
AWWA期刊-硫基还原剂和GAC过滤对二氧化氯副产物的影响

1991-05-01

Commission Regulation (EU) 2017/626 of 31 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad, imazapic, imazapyr, lambda-cyhalothrin, mesotrione, profenofos, propiconazole, pyrimethanil, spirotetramat, tebuconazole, triazophos a
2017年3月31日委员会法规（EU）2017/626修订了欧洲议会和理事会第396/2005号法规（EC）附件二和附件三关于啶虫脒、氰基苯胺、氯氰菊酯、塞浦路斯苯胺、二苯醚甲环唑、乙烯利、氟吡喃、氟三唑、氟xapyroxad、imazapic、imazapyr、λ-三氟氯氰菊酯、mesotrione、profenofos、丙环唑的最大残留量 乙胺嘧啶、螺曲美胺、戊唑醇、三唑磷和

2017-03-31

Council Implementing Decision (EU) 2018/748 of 14 May 2018 on subjecting the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures
2018年5月14日理事会执行决定（欧盟）2018/748 关于对新的精神活性物质1-（4-氰基丁基）-N-（2-苯基丙烷-2-基）-1H-吲唑-3-甲酰胺（异丙基-4CN-BINACA）采取控制措施

2018-05-14

2009/865/EC: Commission Decision of 30 November 2009 allowing Member States to extend provisional authorisations granted for the new active substances metaflumizone and gamma-cyhalothrin (notified under document C(2009) 9366) (Text with EEA relevance)
2009/865/EC:2009年11月30日的委员会决定 允许成员国延长对新活性物质偏氟米松和γ-三氟氯氰菊酯的临时授权（根据C（2009）9366号文件通知）（与欧洲经济区相关的文本）

2009-11-30

Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, for
2019年5月7日委员会实施条例（EU）2019/707修订了第540/2011号实施条例（EU） 涉及延长活性物质α-氯氰菊酯、贝鲁布他胺、苯那氧基、苯噻唑威、联苯苄咱酯、boscalid、溴苯腈、captan、cyazofamid、地塞米松、乐果、二甲酰吗啉、敌草隆、乙烯利、埃托恶唑、法莫沙酮、芬胺磷的批准期 氟米恶嗪、氟沙霉素、folpet、福安磺隆

2019-05-07

Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and z
2017年1月30日委员会第2017/171号法规（EU）修订了欧洲议会和理事会第396/2005号法规（EC）附件二、三和四 涉及氨基比林、偶氮斯特罗宾、氰基转移醇、环氟虫胺、环丙唑、二氟苄草胺、二硫代氨基甲酸酯、氟嗪磷、氟吡仑、卤代磷、异丙胺、甲霜灵、异己二酮、普罗喹唑磷的最大残留量 -乙胺嘧啶、阿托绿木霉SC1和z菌株

2017-01-30